Last updated: May 2026
This page supports a United States–first rollout of GALIMED. It does not constitute legal advice.
GALIMED is operated by Groupe Business Thérapie.
For privacy inquiries, data subject requests, compliance matters, or breach notifications:
📧 contact@groupe-businesstherapie.net
Account Information
Email address; Password hash; User role and authentication data; Technical identifiers and IP addresses.
Health-Related Information
Symptom descriptions; Optional medical or image descriptions; AI-assisted triage inputs; Interaction history and scan history.
Technical Logs
Request identifiers; Security logs; API monitoring data; Error tracking and audit logs.
GALIMED does not replace professional medical care, diagnosis, treatment, or emergency services.
GALIMED may rely on trusted third-party subprocessors and cloud providers, including:
Appropriate Data Processing Agreements (DPAs) and Business Associate Agreements (BAAs) should be executed where legally required.
For a US-first deployment, Microsoft Azure US regions and HIPAA-aligned infrastructure are strongly recommended.
GALIMED should define retention periods for:
Secure deletion, encryption, and backup lifecycle policies should be implemented.
Depending on applicable jurisdiction and privacy laws, users may have rights to:
Requests may be submitted to:
📧 contact@groupe-businesstherapie.net
If GALIMED processes Protected Health Information (PHI), additional HIPAA compliance obligations may apply:
Publishing GALIMED on Microsoft Azure Marketplace generally requires:
A dedicated compliance and certification track with Microsoft is recommended before large-scale commercialization.
GALIMED is not a certified medical device unless explicitly approved by relevant regulatory authorities. AI-generated outputs may contain inaccuracies and require human validation.
In case of medical emergency, users must immediately contact licensed healthcare professionals or emergency services.
© 2026 GALIMED — Groupe Business Thérapie — All rights reserved.